258 related articles for article (PubMed ID: 16555061)
1. Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.
Kamboj SK; Curran HV
Psychopharmacology (Berl); 2006 May; 185(4):529-35. PubMed ID: 16555061
[TBL] [Abstract][Full Text] [Related]
2. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
Kamboj SK; Curran HV
Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions.
Zangara A; Blair RJ; Curran HV
Psychopharmacology (Berl); 2002 Aug; 163(1):36-41. PubMed ID: 12185398
[TBL] [Abstract][Full Text] [Related]
4. Selective impairment in the recognition of anger induced by diazepam.
Blair RJ; Curran HV
Psychopharmacology (Berl); 1999 Dec; 147(3):335-8. PubMed ID: 10639695
[TBL] [Abstract][Full Text] [Related]
5. Effects of diazepam on facial emotion recognition.
Coupland NJ; Singh AJ; Sustrik RA; Ting P; Blair R
J Psychiatry Neurosci; 2003 Nov; 28(6):452-63. PubMed ID: 14631456
[TBL] [Abstract][Full Text] [Related]
6. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.
Curran HV; Pooviboonsuk P; Dalton JA; Lader MH
Psychopharmacology (Berl); 1998 Jan; 135(1):27-36. PubMed ID: 9489931
[TBL] [Abstract][Full Text] [Related]
7. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.
Johnson SA; Stout JC; Solomon AC; Langbehn DR; Aylward EH; Cruce CB; Ross CA; Nance M; Kayson E; Julian-Baros E; Hayden MR; Kieburtz K; Guttman M; Oakes D; Shoulson I; Beglinger L; Duff K; Penziner E; Paulsen JS;
Brain; 2007 Jul; 130(Pt 7):1732-44. PubMed ID: 17584778
[TBL] [Abstract][Full Text] [Related]
8. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
Curran HV; Schifano F; Lader M
Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
[TBL] [Abstract][Full Text] [Related]
9. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.
Thiel CM; Henson RN; Dolan RJ
Neuropsychopharmacology; 2002 Aug; 27(2):282-92. PubMed ID: 12093602
[TBL] [Abstract][Full Text] [Related]
10. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity.
Bertaina-Anglade V; Enjuanes E; Morillon D; Drieu la Rochelle C
J Pharmacol Toxicol Methods; 2006; 54(2):99-105. PubMed ID: 16750402
[TBL] [Abstract][Full Text] [Related]
11. Acute dose-effects of scopolamine on false recognition.
Mintzer MZ; Griffiths RR
Psychopharmacology (Berl); 2001 Feb; 153(4):425-33. PubMed ID: 11243489
[TBL] [Abstract][Full Text] [Related]
12. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
Mintzer MZ; Griffiths RR
Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
[TBL] [Abstract][Full Text] [Related]
13. Disgust and Huntington's disease.
Hayes CJ; Stevenson RJ; Coltheart M
Neuropsychologia; 2007 Mar; 45(6):1135-51. PubMed ID: 17126861
[TBL] [Abstract][Full Text] [Related]
14. Emotion recognition in Huntington's disease and frontotemporal dementia.
Snowden JS; Austin NA; Sembi S; Thompson JC; Craufurd D; Neary D
Neuropsychologia; 2008 Sep; 46(11):2638-49. PubMed ID: 18533200
[TBL] [Abstract][Full Text] [Related]
15. The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease.
Calder AJ; Keane J; Young AW; Lawrence AD; Mason S; Barker RA
Neuropsychologia; 2010 Jul; 48(9):2719-29. PubMed ID: 20580641
[TBL] [Abstract][Full Text] [Related]
16. Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
Fernández-Serrano MJ; Lozano O; Pérez-García M; Verdejo-García A
Drug Alcohol Depend; 2010 Jun; 109(1-3):57-64. PubMed ID: 20064697
[TBL] [Abstract][Full Text] [Related]
17. Loss of disgust. Perception of faces and emotions in Huntington's disease.
Sprengelmeyer R; Young AW; Calder AJ; Karnat A; Lange H; Hömberg V; Perrett DI; Rowland D
Brain; 1996 Oct; 119 ( Pt 5)():1647-65. PubMed ID: 8931587
[TBL] [Abstract][Full Text] [Related]
18. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
Duka T; Ott H; Rohloff A; Voet B
Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
Mintzer MZ; Griffiths RR
Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383
[TBL] [Abstract][Full Text] [Related]
20. The influence of alcohol intake and alcohol expectations on the recognition of emotions.
Walter NT; Mutic S; Markett S; Montag C; Klein AM; Reuter M
Alcohol Alcohol; 2011; 46(6):680-5. PubMed ID: 21749998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
